PURPOSE: To evaluate the feasibility to detect tumors and metastases by the chemical exchange saturation transfer (CEST) MRI technique using 3-O-Methyl-D-glucose (3OMG), a nonmetabolizable derivative of glucose that is taken up rapidly and preferentially by tumors and is entirely excreted by the kidneys. METHODS: In vivo CEST MRI experiments were performed on a Bruker 7 Tesla Biospec on implanted orthotopic mammary tumors of mice before and following i.p. injection of 3OMG. The CEST images were generated by a series of gradient-echo images collected from a single 1 mm coronal slice after a 1.2 s presaturation pulse, applied at offsets of ±1.2 ppm from the water and at B(1) power of 2.5 µT. RESULTS: Following 3OMG (1.5 g/kg) i.p. injection, an enhanced CEST effect of approximately 20% was visualized at the tumor within a few minutes. The signal slowly declined reaching half of its maximum at approximately 80 min. CONCLUSION: Due to the large CEST effect of 3OMG and its low toxicity 3OMG-CEST may serve for the detection of tumors and metastases in the clinic.
PURPOSE: To evaluate the feasibility to detect tumors and metastases by the chemical exchange saturation transfer (CEST) MRI technique using 3-O-Methyl-D-glucose (3OMG), a nonmetabolizable derivative of glucose that is taken up rapidly and preferentially by tumors and is entirely excreted by the kidneys. METHODS: In vivo CEST MRI experiments were performed on a Bruker 7 Tesla Biospec on implanted orthotopic mammary tumors of mice before and following i.p. injection of 3OMG. The CEST images were generated by a series of gradient-echo images collected from a single 1 mm coronal slice after a 1.2 s presaturation pulse, applied at offsets of ±1.2 ppm from the water and at B(1) power of 2.5 µT. RESULTS: Following 3OMG (1.5 g/kg) i.p. injection, an enhanced CEST effect of approximately 20% was visualized at the tumor within a few minutes. The signal slowly declined reaching half of its maximum at approximately 80 min. CONCLUSION: Due to the large CEST effect of 3OMG and its low toxicity3OMG-CEST may serve for the detection of tumors and metastases in the clinic.
Authors: Wojciech G Lesniak; Nikita Oskolkov; Xiaolei Song; Bachchu Lal; Xing Yang; Martin Pomper; John Laterra; Sridhar Nimmagadda; Michael T McMahon Journal: Nano Lett Date: 2016-03-01 Impact factor: 11.189
Authors: Xiang Xu; Akansha Ashvani Sehgal; Nirbhay N Yadav; John Laterra; Lindsay Blair; Jaishri Blakeley; Anina Seidemo; Jennifer M Coughlin; Martin G Pomper; Linda Knutsson; Peter C M van Zijl Journal: Magn Reson Med Date: 2019-12-24 Impact factor: 4.668
Authors: Xiang Xu; Jiadi Xu; Kannie W Y Chan; Jing Liu; Huanling Liu; Yuguo Li; Lin Chen; Guanshu Liu; Peter C M van Zijl Journal: Magn Reson Med Date: 2018-07-29 Impact factor: 4.668
Authors: Xiao-Yong Zhang; Feng Wang; Tao Jin; Junzhong Xu; Jingping Xie; Daniel F Gochberg; John C Gore; Zhongliang Zu Journal: Magn Reson Med Date: 2016-09-08 Impact factor: 4.668
Authors: Xiang Xu; Kannie W Y Chan; Linda Knutsson; Dmitri Artemov; Jiadi Xu; Guanshu Liu; Yoshinori Kato; Bachchu Lal; John Laterra; Michael T McMahon; Peter C M van Zijl Journal: Magn Reson Med Date: 2015-09-25 Impact factor: 4.668